Jerel Davis's Form 4 filing
Turnstone Biologics Corp. (TSBX) · filed Jul 27, 2023
- Accession no.
- 0001209191-23-043525
- Filed
- Jul 27, 2023
- Trade date
- Jul 25, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 17 derivative transactions. Open-market purchases total $2.70M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jerel DavisCIK 0001745958 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 25, 2023 | Common Stock | CConversionAcquired | +2,528,864 | –F1 | – | 2,528,864 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionAcquired | +192,458 | –F1 | – | 192,458 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionAcquired | +84,313 | –F1 | – | 84,313 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionAcquired | +76,067 | –F1 | – | 76,067 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionAcquired | +274,990 | –F1 | – | 274,990 | Indirect | |
| Jul 25, 2023 | Common Stock | PPurchaseAcquired | +197,458 | $12.00 | +$2,369,496 | 2,726,322 | Indirect | |
| Jul 25, 2023 | Common Stock | PPurchaseAcquired | +15,028 | $12.00 | +$180,336 | 207,486 | Indirect | |
| Jul 25, 2023 | Common Stock | PPurchaseAcquired | +6,575 | $12.00 | +$78,900 | 90,888 | Indirect | |
| Jul 25, 2023 | Common Stock | PPurchaseAcquired | +5,939 | $12.00 | +$71,268 | 82,006 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 25, 2023 | Common Stock | CConversionDisposed | −988,832 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −75,255 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −32,971 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −29,744 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −442,055 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −33,642 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −14,739 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −13,297 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −957,787 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −72,892 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −31,936 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −28,810 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −140,190 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −10,669 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −4,667 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −4,216 | $0.00 | $0 | 0 | Indirect | |
| Jul 25, 2023 | Common Stock | CConversionDisposed | −274,990 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date.
Referenced by the price of 5 transactions in Table I.